| Overview |
| bs-9351R-PE-Cy7 |
| Proteasome 20S alpha 2 Antibody, PE-Cy7 Conjugated |
| WB |
| Human, Mouse, Rat |
| Specifications |
| PE-Cy7 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Proteasome 20S alpha 2 |
| 1-100/234 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 5683 |
| 20S Proteasome 2; HC3; Macropain subunit C3; MU antibody Multicatalytic endopeptidase complex subunit C3; PMSA2; Proteasome prosome macropain subunit alpha type 2; Proteasome alpha 2 subunit; Proteasome component C3; Proteasome subunit alpha type 2; Proteasome subunit alpha type-2; Proteasome subunit HC3; PSC2; PSC3; PSMA 2; psmA2; PSA2_HUMAN. |
| The proteasome is a multicatalytic proteinase complex which is characterized by its ability to cleave peptides with Arg, Phe, Tyr, Leu, and Glu adjacent to the leaving group at neutral or slightly basic pH. The proteasome has an ATP-dependent proteolytic activity. PSMA2 may have a potential regulatory effect on another component(s) of the proteasome complex through tyrosine phosphorylation. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz